Short interfering RNAs targeting a vampire-bat related rabies virus phosphoprotein mRNA

AUTOR(ES)

Ono, Ekaterina Alexandrovna Durymanova, Taniwaki, Sueli Akemi, Brandão, Paulo

FONTE

Braz. J. Microbiol.

DATA DE PUBLICAÇÃO

2017-07

RESUMO

Abstract The aim of this study was to assess the in vitro and in vivo effects of short-interfering RNAs (siRNAs) against rabies virus phosphoprotein (P) mRNA in a post-infection treatment for rabies as an extension of a previous report (Braz J Microbiol. 2013 Nov 15;44(3):879-82). To this end, rabies virus strain RABV-4005 (related to the Desmodus rotundus vampire bat) were used to inoculate BHK-21 cells and mice, and the transfection with each of the siRNAs was made with Lipofectamine-2000™. In vitro results showed that siRNA 360 was able to inhibit the replication of strain RABV-4005 with a 1 log decrease in virus titter and 5.16-fold reduction in P mRNA, 24 h post-inoculation when compared to non-treated cells. In vivo, siRNA 360 was able to induce partial protection, but with no significant difference when compared to non-treated mice. These results indicate that, despite the need for improvement for in vivo applications, P mRNA might be a target for an RNAi-based treatment for rabies.

Documentos Relacionados

• Short-interfering RNAs as antivirals against rabies
• mRNA activity of a Sindbis virus defective-interfering RNA.
• MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms
• Evaluation of short-interfering RNAs treatment in experimental rabies due to wild-type virus
• Translation initiation at alternate in-frame AUG codons in the rabies virus phosphoprotein mRNA is mediated by a ribosomal leaky scanning mechanism.